Compare peptides
Put two entries side by side — evidence, mechanism, risks, and community claims.
Cardiogen (AEDR)
Preclinical
Research chemical
Summary
Khavinson-class tetrapeptide bioregulator (Ala-Glu-Asp-Arg) studied for cardiomyocyte gene regulation, anti-apoptosis, and cardiac tissue support in Russian bioregulator literature.
Categories
Longevity, Healing & Recovery
Mechanism
Proposed epigenetic bioregulator mechanism: nuclear entry, DNA/histone interaction (H1, H2B, H3, H4), chromatin decondensation, and tissue-specific gene reactivation in cardiomyocytes. Organotypic myocardial cultures report stimulated cardiomyocyte proliferation with p53 downregulation and upregulation of cytoskeletal/nuclear matrix proteins. Also discussed in SASP/inflammaging cardiovascular reviews from the same group.
Half-life
Ultrashort peptide — plasma minutes; proposed transcriptional effects longer
Routes
Subcutaneous injection; Oral
Legal / access
Not FDA-evaluated. Sold as research peptide / Russian bioregulator class. Not a substitute for cardiovascular medicine.
Key risks
- Limited Western safety dataset
- Unknown interactions with cardiac drugs
Common claims
- Heart tissue support
- Cardiac aging narratives
- Stack with other Khavinson peptides
Select peptide B